Limin GroupLtd Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Limin GroupLtd's earnings have been declining at an average annual rate of -33.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 4.5% per year. Limin GroupLtd's return on equity is 3.7%, and it has net margins of 2.2%.
Información clave
-33.7%
Tasa de crecimiento de los beneficios
-34.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.1% |
| Tasa de crecimiento de los ingresos | 4.5% |
| Rentabilidad financiera | 3.7% |
| Margen neto | 2.2% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Desglose de ingresos y gastos
Cómo gana y gasta dinero Limin GroupLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 4,170 | 91 | 370 | 144 |
| 30 Jun 24 | 4,216 | 36 | 378 | 144 |
| 31 Mar 24 | 4,032 | -6 | 374 | 146 |
| 31 Dec 23 | 4,224 | 62 | 385 | 147 |
| 30 Sep 23 | 4,372 | 62 | 421 | 173 |
| 30 Jun 23 | 4,514 | 125 | 431 | 189 |
| 31 Mar 23 | 4,952 | 181 | 440 | 199 |
| 01 Jan 23 | 5,016 | 219 | 437 | 196 |
| 30 Sep 22 | 5,078 | 216 | 477 | 178 |
| 30 Jun 22 | 5,006 | 211 | 470 | 178 |
| 31 Mar 22 | 4,705 | 243 | 450 | 178 |
| 01 Jan 22 | 4,738 | 307 | 438 | 184 |
| 30 Sep 21 | 4,495 | 282 | 339 | 183 |
| 30 Jun 21 | 4,273 | 328 | 347 | 175 |
| 31 Mar 21 | 4,341 | 404 | 370 | 169 |
| 31 Dec 20 | 4,388 | 386 | 402 | 175 |
| 30 Sep 20 | 4,414 | 409 | 531 | 188 |
| 30 Jun 20 | 4,401 | 428 | 537 | 178 |
| 31 Mar 20 | 3,761 | 382 | 488 | 157 |
| 31 Dec 19 | 2,833 | 322 | 403 | 128 |
| 30 Sep 19 | 2,454 | 342 | 326 | 88 |
| 30 Jun 19 | 1,894 | 302 | 244 | 62 |
| 31 Mar 19 | 1,555 | 230 | 221 | 57 |
| 31 Dec 18 | 1,519 | 206 | 211 | 57 |
| 30 Sep 18 | 1,503 | 176 | 189 | 56 |
| 30 Jun 18 | 1,475 | 161 | 175 | 78 |
| 31 Mar 18 | 1,440 | 145 | 188 | 64 |
| 31 Dec 17 | 1,423 | 137 | 190 | 54 |
| 30 Sep 17 | 1,371 | 155 | 216 | 33 |
| 30 Jun 17 | 1,283 | 133 | 225 | 0 |
| 31 Mar 17 | 1,250 | 135 | 213 | 0 |
| 31 Dec 16 | 1,160 | 113 | 214 | 0 |
| 30 Sep 16 | 1,003 | 101 | 175 | 0 |
| 30 Jun 16 | 936 | 96 | 162 | 0 |
| 31 Mar 16 | 871 | 82 | 149 | 0 |
| 31 Dec 15 | 835 | 67 | 142 | 0 |
| 30 Sep 15 | 809 | 48 | 132 | 0 |
| 30 Jun 15 | 781 | 49 | 122 | 0 |
| 31 Mar 15 | 785 | 49 | 112 | 0 |
| 31 Dec 14 | 758 | 48 | 105 | 0 |
| 31 Dec 13 | 666 | 52 | 95 | 0 |
Ingresos de calidad: 002734 has a large one-off gain of CN¥21.3M impacting its last 12 months of financial results to 30th September, 2024.
Margen de beneficios creciente: 002734's current net profit margins (2.2%) are higher than last year (1.4%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 002734's earnings have declined by 33.7% per year over the past 5 years.
Acelerando crecimiento: 002734's earnings growth over the past year (47.1%) exceeds its 5-year average (-33.7% per year).
Beneficios vs. Industria: 002734 earnings growth over the past year (47.1%) exceeded the Chemicals industry -3.8%.
Rentabilidad financiera
Alta ROE: 002734's Return on Equity (3.7%) is considered low.